Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSMA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC25A3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP5G3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ACP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
VDAC3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DLAT - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAT2B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MARCKS - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WDR61 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
APEX1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DYNC2LI1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
INSIG2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CUL3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LOC101930404 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BRMS1L - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
KPNA2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAPZA2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on